Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces Third Quarter 2011 Results

VANCOUVER, British Columbia, Nov. 8, 2011 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced its financial and operational results for the third quarter ended September 30, 2011.

MORE ON THIS TOPIC